Glaucoma Treatment Market (Prostaglandin Analogs, Beta Blockers, Alpha Agonist)

Date: 22 December 2018

The segment of Prostaglandin Analogs witnessed growth at a noteworthy rate over the past few years backed by increased prevalence of glaucoma, easy availability of dug along with rising number of hospitals and their respective pharmacies. Amongst the regions, North America accounts for the largest regional share in the global glaucoma treatment market in 2018. Key factors driving the robust growth rate of North America region include Well developed healthcare infrastructure, favorable regulatory reforms, rising prevalence of glaucoma in the region.

What are the major Glaucoma Treatment segments covered in the Azoth Analytics report?

The major Glaucoma Treatment segments covered in the report include Open Angle Glaucoma, Closed Angle Glaucoma, Secondary Glaucoma, Congenital Glaucoma, Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors, Others.

What are the regions and countries covered in the study on Glaucoma Treatment market?

The regional markets covered in the report include North America, Europe, APAC and Rest of the World.

The countries analyzed in the report include U.S., Canada, Germany, United Kingdom, India, Japan China, Brazil

Name the companies profiled in the report?

The companies profiled in the report include Evonik Industries, Bayer Healthcare AG and Zimmer Biomet Holdings Inc.

What are the key factors driving the market of Glaucoma Treatment?

·         Rising Old Age Population

·         Increasing prevalence of Glaucoma

·         Rising Healthcare Expenditure Worldwide